Article Data

  • Views 347
  • Dowloads 113

Original Research

Open Access

The role of ovarian transposition in patients with early stage cervical cancer - two case reports

  • N. Salakos1
  • K. Bakalianou1
  • C. Iavazzo1,*,
  • G. Paltoglou1
  • K. Papadias1
  • A. Liapis1
  • A. Kondi-Pafiti1

12nd Department of Obstetrics and Gynecology, Medical School, University of Athens, Aretaieion Hospital, Athens, Greece

DOI: 10.12892/ejgo200803280 Vol.29,Issue 3,May 2008 pp.280-281

Published: 10 May 2008

*Corresponding Author(s): C. Iavazzo E-mail: christosiavazzo@hotmail.com

Abstract

The aim of the study is to present two cases of premenopausal women with early stage cervical carcinoma who underwent ovarian transposition. The role and the advantages of this technique are discussed.

Keywords

Early stage cervical carcinoma; Ovarian transposition; Preservation; Menopause; Fertility

Cite and Share

N. Salakos,K. Bakalianou,C. Iavazzo,G. Paltoglou,K. Papadias,A. Liapis,A. Kondi-Pafiti. The role of ovarian transposition in patients with early stage cervical cancer - two case reports. European Journal of Gynaecological Oncology. 2008. 29(3);280-281.

References

[1] DeCherney A., Nathan A. (eds.) Current Obstetric and Gynecologic Diagnosis and Treatment, 9th edition, New York, McGraw Hill, 2003.

[2] Duska L.R., Toth T.L., Goodman A.: “Fertility options for patients with Stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues”. Obstet. Gynecol., 1998, 92 (4 pt 2), 656.

[3] Sella T., Mironov S., Hricak H.: “Imaging of transposed ovaries in patients with cervical carcinoma”. AJR, 2005, 184, 1602.

[4] Morice P., Juncker L., Rey A., El-Hassan J., Haie-Meder C., Castaigne D.: “Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination”. Fertil. Steril., 2000, 74, 743.

[5] Ishii K., Aoki Y., Takakuwa K., Tanaka K.: “Ovarian function after radical hysterectomy with ovarian preservation for cervical cancer”. J. Reprod. Med., 2001, 46, 347.

[6] Olejek A., Wala D., Chimiczewski P., Rzempoluch J.: “Hormonal activity of transposed ovaries in young women treated for cervical cancer”. Gynecol. Endocrinol., 2001, 15, 5.

[7] Wu X.H., Li Z.T., Huang X., Zhou Y.Q., Cheng X., Cai S.M., Zhang Z.Y.: “Transposed ovarian function conservation in cervical cancer patients with radiotherapy”. Zhonghua Fu Chan Ke Za Zhi., 2005, 40, 220.

[8] Buekers T.E., Anderson B., Sorosky J.I., Buller R.E.: “Ovarian function after surgical treatment for cervical cancer”. Gynecol. Oncol., 2001, 80, 85.

[9] Feeney D.D., Moore D.H., Look K.Y., Stehman F.B., Sutton G.P.: “The fate of the ovaries after radical hysterectomy and ovarian transposition”. Gynecol. Oncol., 1995, 56, 3.

[10] Bidzin´ski M, Lemieszczuk B, Zielin´ski J.: “Evaluation of the hormonal function and features of the ultrasound picture of transposed ovary in cervical cancer patients after surgery and pelvic irradiation”. Eur. J. Gynaecol. Oncol., 1993, 14 (suppl.), 77.

[11] Van Eijkeren M.A., Van Der Wijk I., El Sharouni S.Y., Heintz A.P.: “Benefits and side effects of lateral ovarian transposition (LOT) performed during radical hysterectomy and pelvic lymphadenectomy for early stage cervical cancer”. Int. J. Gynecol. Cancer., 1999, 9, 396.

[12] Olejek A., Rzempoluch J., Adamczyk S., Binkiewicz P., Chimiczewski P.: “Surgical procedure connected complications in women with cervical cancer operated with ovarian transposition (transpositio ovariorum)”. Ginekol. Pol., 1998, 69, 644.

[13] Owens S., Roberts W.S., Fiorica J.V., Hoffman M.S., LaPolla J.P., Cavanagh D.: “Ovarian management at the time of radical hysterectomy for cancer of the cervix”. Gynecol. Oncol., 1989, 35, 349.

[14] Nguyen L., Brewer C.A., DiSaia P.J.: “Ovarian metastasis of Stage IB1 squamous cell cancer of the cervix after radical parametrectomy and oophoropexy”. Gynecol. Oncol., 1998, 68, 198.

[15] Landoni F., Zanagnolo V., Lovato-Diaz L., Maneo A., Rossi R., Gadducci A. et al.: “Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)”. Int. J. Gynecol. Cancer, 2007, 17, 623.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top